Content Validation of an Algorithm for the Assessment, Management and Monitoring of Drug-Induced QTc Prolongation in the Psychiatric Population
- PMID: 34848960
- PMCID: PMC8612668
- DOI: 10.2147/NDT.S334350
Content Validation of an Algorithm for the Assessment, Management and Monitoring of Drug-Induced QTc Prolongation in the Psychiatric Population
Abstract
Background: QTc interval (QTcI) prolongation leads to serious complications, making it a concern for clinicians. Assessing the risk of QTcI prolongation in the psychiatric population is important because they are exposed to multiple medications known to increase the risk of life-threatening arrhythmias.
Aim: The study aims to validate the content of an algorithm for the assessment, management and monitoring of drug-induced QTc prolongation in the psychiatric population.
Methodology: Qualitative semi-structured interviews of cardiologists, to gather information regarding their approach in assessing the risk of drug-induced QTc prolongation at the time of prescribing. After the interview, an orientation to the algorithm was provided with a link to a cross-sectional, anonymous survey. The online survey included quantitative and qualitative components to gather feedback on the relevance and appropriateness of each step in the algorithm.
Results: Interview responses were incorporated into 4 themes. Responses indicated a lack of a unified protocol when assessing QTcI prolongation, which supports the need of an algorithm that includes a verified risk scoring tool. Quantitative survey results showed a mean score ranging from 3.08 to 3.67 out of 4 for the appropriateness of the algorithm's steps, 3.08 to 3.58 for the safety and 3.17 to 3.75 for the reliability of references used. Additional analysis using the modified kappa and I-CVI statistical measures indicate high validity of contents and high degree of agreement between raters. As per the open-ended questions, cardiologists supported the implementation of the algorithm; however, they recommended simplification of the steps as they appear to be cumbersome.
Conclusion: The results demonstrate that the implementation of the algorithm after minor alterations can prove to be useful as a tool for the risk assessment of QTc prolongation. Further validation of the algorithm with mental health pharmacists and clinicians will be conducted as a separate phase of the study.
Keywords: QTc prolongation; algorithm; drug-induced arrhythmias; psychiatric population.
© 2021 Zolezzi et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Assessment of Drug-Induced QTc Prolongation in Mental Health Practice: Validation of an Evidence-Based Algorithm.Risk Manag Healthc Policy. 2023 Oct 13;16:2113-2124. doi: 10.2147/RMHP.S426591. eCollection 2023. Risk Manag Healthc Policy. 2023. PMID: 37854638 Free PMC article.
-
Pharmacist Reported Protocols for QTc Monitoring of Psychiatric Medications.Cureus. 2024 Mar 29;16(3):e57192. doi: 10.7759/cureus.57192. eCollection 2024 Mar. Cureus. 2024. PMID: 38681387 Free PMC article.
-
A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population.Neuropsychiatr Dis Treat. 2018 Dec 24;15:105-114. doi: 10.2147/NDT.S186474. eCollection 2019. Neuropsychiatr Dis Treat. 2018. PMID: 30636876 Free PMC article. Review.
-
Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.Clin Drug Investig. 2010;30(9):599-611. doi: 10.2165/11537210-000000000-00000. Clin Drug Investig. 2010. PMID: 20568829 Clinical Trial.
-
Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review.Pharmacotherapy. 2018 Aug;38(8):813-821. doi: 10.1002/phar.2146. Epub 2018 Jul 18. Pharmacotherapy. 2018. PMID: 29882591
Cited by
-
Assessment of Drug-Induced QTc Prolongation in Mental Health Practice: Validation of an Evidence-Based Algorithm.Risk Manag Healthc Policy. 2023 Oct 13;16:2113-2124. doi: 10.2147/RMHP.S426591. eCollection 2023. Risk Manag Healthc Policy. 2023. PMID: 37854638 Free PMC article.
-
Pharmacist Reported Protocols for QTc Monitoring of Psychiatric Medications.Cureus. 2024 Mar 29;16(3):e57192. doi: 10.7759/cureus.57192. eCollection 2024 Mar. Cureus. 2024. PMID: 38681387 Free PMC article.
-
Risk Stratification of QTc Prolongations in Hospitalized Cardiology and Gastroenterology Patients Using the Tisdale Score-A Retrospective Analysis.J Clin Med. 2025 Jan 8;14(2):339. doi: 10.3390/jcm14020339. J Clin Med. 2025. PMID: 39860345 Free PMC article.
-
Validation of a Clinical Decision Support Tool for Quantifying Risk of Torsades de Pointes in a Psychiatric Inpatient Population.Innov Clin Neurosci. 2025 Jun 1;22(4-6):14-19. eCollection 2025 Apr-Jun. Innov Clin Neurosci. 2025. PMID: 40786905 Free PMC article.
References
-
- Correll CU, Solmi M, Veronese N, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163–180. doi:10.1002/wps.20420 - DOI - PMC - PubMed
-
- Girardin F, Sztajzel J. Cardiac adverse reactions associated with psychotropic drugs. Dialogues Clin Neurosci. 2007;9(1):92–95.
LinkOut - more resources
Full Text Sources
Research Materials